PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.67%
Negative revenue growth while SNAP stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-2.50%
Negative gross profit growth while SNAP is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
1.09%
EBIT growth of 1.09% while SNAP is zero. Bruce Berkowitz would see if small gains can be scaled further.
1.09%
Operating income growth of 1.09% while SNAP is zero. Bruce Berkowitz would see if this modest edge can become significant.
-26.11%
Negative net income growth while SNAP stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-25.71%
Negative EPS growth while SNAP is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.71%
Negative diluted EPS growth while SNAP is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.29%
Share change of 0.29% while SNAP is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.15%
Diluted share change of 0.15% while SNAP is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
3.98%
OCF growth of 3.98% while SNAP is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
31.18%
FCF growth of 31.18% while SNAP is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
973.53%
10Y CAGR of 973.53% while SNAP is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
137.85%
5Y CAGR of 137.85% while SNAP is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
54.90%
3Y CAGR of 54.90% while SNAP is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
876.53%
OCF/share CAGR of 876.53% while SNAP is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
139.11%
OCF/share CAGR of 139.11% while SNAP is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
71.15%
3Y OCF/share CAGR of 71.15% while SNAP is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
644.16%
10Y net income/share CAGR of 644.16% while SNAP is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
67.88%
Net income/share CAGR of 67.88% while SNAP is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
16.21%
3Y net income/share CAGR of 16.21% while SNAP is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
2373.53%
Equity/share CAGR of 2373.53% while SNAP is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
164.51%
Equity/share CAGR of 164.51% while SNAP is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
67.91%
Equity/share CAGR of 67.91% while SNAP is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.97%
Firm’s AR is declining while SNAP shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-35.93%
Inventory is declining while SNAP stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.73%
Asset growth of 1.73% while SNAP is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
3.48%
BV/share growth of 3.48% while SNAP is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-0.04%
We’re deleveraging while SNAP stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-2.13%
Our R&D shrinks while SNAP invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-6.75%
We cut SG&A while SNAP invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.